×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

Contexte :

 

Après plusieurs décennies sans avancées majeures, de nouvelles molécules viennent redéfinir la prise en charge des cancers de l’endomètre.

 

Deux experts vous partagent leur analyse des données actuelles et des dernières recommandations à travers des cas cliniques.

 

Experts :

 

Pr Jean-Sébastien Frenel - Oncologue médical, Institut de Cancérologie de l’Ouest, Saint-Herblain

Pr Isabelle Ray-Coquard - Oncologue médical, Centre Léon Bérard, Lyon

 

Programme :

 

- Présentation des recommandations de Saint Paul de Vence 2025 dans les cancers de l’endomètre avancé ou en rechute

Jean Sébastien Frenel

 

- Cas clinique 1 : Prise en charge des tumeurs dMMR

Isabelle Ray-Coquard

 

- Cas clinique 2 : Prise en charge des tumeurs pMMR

Jean Sébastien Frenel

 

- Débat/Discussion & Réponses aux questions

 

Shooting date : 2025-06-11
Last update : 2025-07-07
Jean-Sébastien Frenel
Saint-Herblain, France
Oncology

Suggestions

Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Honolulu : Monday, April 28th 2025 from 06:30am to 07:30am (GMT+2)
San Francisco : Monday, April 28th 2025 from 09:30am to 10:30am (GMT+2)
New York : Monday, April 28th 2025 from 12:30pm to 01:30pm (GMT+2)
Buenos Aires : Monday, April 28th 2025 from 01:30pm to 02:30pm (GMT+2)
Reykjavik : Monday, April 28th 2025 from 04:30pm to 05:30pm (GMT+2)
London / Dublin : Monday, April 28th 2025 from 05:30pm to 06:30pm (GMT+2)
Paris / Berlin : Monday, April 28th 2025 from 06:30pm to 07:30pm (GMT+2)
Istanbul : Monday, April 28th 2025 from 07:30pm to 08:30pm (GMT+2)
Moscou / Dubaï : Monday, April 28th 2025 from 08:30pm to 09:30pm (GMT+2)
Bangkok : Monday, April 28th 2025 from 11:30pm to 12:30am (GMT+2)
Shanghai : Tuesday, April 29th 2025 from 12:30am to 01:30am (GMT+2)
Tokyo : Tuesday, April 29th 2025 from 01:30am to 02:30am (GMT+2)
Sydney : Tuesday, April 29th 2025 from 03:30am to 04:30am (GMT+2)
Wellington : Tuesday, April 29th 2025 from 05:30am to 06:30am (GMT+2)

PARPi dans le cancer de l'ovaire en 1L

Données actuelles et perspectives pour la combinaison avec l’IO

Share
0
Days
0
Hours
0
Minutes
0
Seconds
Tuesday, September 16th 2025 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 16th 2025 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 16th 2025 from 09am to 10:30am (GMT+2)
New York : Tuesday, September 16th 2025 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, September 16th 2025 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, September 16th 2025 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, September 16th 2025 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, September 16th 2025 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 16th 2025 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 16th 2025 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, September 16th 2025 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, September 17th 2025 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, September 17th 2025 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, September 17th 2025 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, September 17th 2025 from 05am to 06:30am (GMT+2)

Cancer de l'ovaire : nouveautés en première ligne

Tuesday, October 11th 2022 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, October 11th 2022 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, October 11th 2022 from 09am to 10:30am (GMT+2)
New York : Tuesday, October 11th 2022 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, October 11th 2022 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, October 11th 2022 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, October 11th 2022 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, October 11th 2022 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, October 11th 2022 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, October 11th 2022 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, October 11th 2022 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, October 12th 2022 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, October 12th 2022 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, October 12th 2022 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, October 12th 2022 from 05am to 06:30am (GMT+2)

Cancer de l’ovaire

Share
Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Monday, September 25th 2023 from 06:30am to 08am (GMT+2)
San Francisco : Monday, September 25th 2023 from 09:30am to 11am (GMT+2)
New York : Monday, September 25th 2023 from 12:30pm to 02pm (GMT+2)
Buenos Aires : Monday, September 25th 2023 from 01:30pm to 03pm (GMT+2)
Reykjavik : Monday, September 25th 2023 from 04:30pm to 06pm (GMT+2)
London / Dublin : Monday, September 25th 2023 from 05:30pm to 07pm (GMT+2)
Paris / Berlin : Monday, September 25th 2023 from 06:30pm to 08pm (GMT+2)
Istanbul : Monday, September 25th 2023 from 07:30pm to 09pm (GMT+2)
Moscou / Dubaï : Monday, September 25th 2023 from 08:30pm to 10pm (GMT+2)
Bangkok : Monday, September 25th 2023 from 11:30pm to 01am (GMT+2)
Shanghai : Tuesday, September 26th 2023 from 12:30am to 02am (GMT+2)
Tokyo : Tuesday, September 26th 2023 from 01:30am to 03am (GMT+2)
Sydney : Tuesday, September 26th 2023 from 03:30am to 05am (GMT+2)
Wellington : Tuesday, September 26th 2023 from 05:30am to 07am (GMT+2)

Les scores indispensables dans la prise en charge des cancers de l'ovaire

Cycle d'enseignement - Les cancers gynécologiques

Share
Scroll Up